Showing results (71-80 of 92) with videos related to
Sort By:
Pageof 10
Journal of Drugs in Dermatology : JDD|February 5, 2013
Clearance of nasal Staphylococcus aureus colonization with triple antibiotic ointmentElizabeth M Grossman, Shivani Nanda, Jennifer R S Gordon, et al.JAMA Dermatology|September 24, 2015
Palliative Therapy for Recalcitrant Cutaneous T-Cell Lymphoma of the Hands and Feet With Low-Dose, High Dose-Rate BrachytherapyAllison L Goddard, Ruth Ann Vleugels, Nicole R LeBoeuf, et al.American Journal of Clinical Dermatology|April 17, 2026
Identifying the Most Relevant Eczema Area and Severity Index Thresholds from the Patient Perspective in Atopic Dermatitis TreatmentLawrence F Eichenfield, Peter A Lio, Alan D Irvine, et al.Journal of the American Academy of Dermatology|January 17, 2015
A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatosesTamar Hajar, Yael A Leshem, Jon M Hanifin, et al.JAAD International|May 22, 2024
Improving systemic therapy selection for inflammatory skin diseases: A clinical need surveyNicholas D Brownstone, Aaron S Farberg, Graham H Litchman, et al.The Journal of Dermatological Treatment|June 28, 2021
Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapyPeter A Lio, Eric L Simpson, George Han, et al.The Journal of Dermatological Treatment|June 1, 2026
Benefit-risk profile comparison between dupilumab and upadacitinib: a structured benefit-risk assessment of the Heads Up trialAndrew Blauvelt, Eric L Simpson, Kilian Eyerich, et al.Journal of Drugs in Dermatology : JDD|October 7, 2020
Atopic Dermatitis and the Role of the Skin Microbiome in Choosing Prevention, Treatment, and Maintenance OptionsHilary Baldwin, Crystal Aguh, Anneke Andriessen, et al.Dermatology and Therapy|June 26, 2024
Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic DermatitisPeter A Lio, April Armstrong, Jan Gutermuth, et al.Dermatology and Therapy|May 11, 2022
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records DatasetLawrence F Eichenfield, April Armstrong, Emma Guttman-Yassky, et al.Pageof 10